Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell-based drug delivery.

F Pierigè1, S Serafini, L Rossi

  • 1Institute of Biological Chemistry Giorgio Fornaini, University of Urbino Carlo Bo, Urbino, Italy.

Advanced Drug Delivery Reviews
|November 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved cellular uptake of functionalized single-walled carbon nanotubes.

Nanotechnology·2010
Same author

Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS).

Antiviral research·2008
Same author

Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir.

Nucleosides, nucleotides & nucleic acids·2007
Same author

Erythrocytes as a controlled drug delivery system: clinical evidences.

Journal of controlled release : official journal of the Controlled Release Society·2007
Same author

The polymorphism of multi-drug resistance 1 gene (MDR1) does not influence the pharmacokinetics of dexamethasone loaded into autologous erythrocytes of patients with inflammatory bowel disease.

European review for medical and pharmacological sciences·2006
Same author

Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages.

The Journal of antimicrobial chemotherapy·2004
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Erythrocyte-based drug delivery systems offer prolonged release, high capacity, and biocompatibility for various drugs. These safe and effective carriers show promise for managing complex diseases and reducing side effects.

Area of Science:

  • Biomedical Engineering
  • Pharmacology
  • Hematology

Background:

  • Traditional drug delivery methods face limitations in bioavailability, pharmacokinetics, and toxicity.
  • Cell-based delivery systems, including erythrocytes, offer advantages like prolonged release and targeted delivery.
  • Erythrocytes (red blood cells) are explored as efficient carriers for both traditional and biologic drugs.

Purpose of the Study:

  • To highlight the potential of erythrocyte-based drug delivery systems.
  • To discuss the advantages of using erythrocytes as drug carriers.
  • To emphasize the safety and efficacy of erythrocyte-based treatments.

Main Methods:

  • Focus on erythrocyte-based drug delivery systems.
  • Review of carrier erythrocytes' properties and applications.

Related Experiment Videos

  • Evaluation of drug administration in human studies.

    • Main Results:

    • Erythrocyte systems provide prolonged drug release (weeks) and have large drug-carrying capacity.
    • These systems can accommodate diverse drug types (traditional and biologic) and are easily processed.
    • Carrier erythrocytes have demonstrated safety and efficacy in numerous human administrations.

    Conclusions:

    • Erythrocyte-based drug delivery is a promising approach for enhancing therapeutic outcomes.
    • This method is particularly beneficial for managing complex pathologies where side effects are a concern.
    • Further interest in erythrocyte drug delivery is driven by its potential to improve treatment efficacy and patient safety.